trifluralin has been researched along with Leishmaniasis, Visceral in 3 studies
Trifluralin: A microtubule-disrupting pre-emergence herbicide.
trifluralin : A substituted aniline that is N,N-dipropylaniline substituted by a nitro groups at positions 2 and 6 and a trifluoromethyl group at position 4. It is an agrochemical used as a pre-emergence herbicide.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalheiro, M | 3 |
| Esteves, MA | 2 |
| Santos-Mateus, D | 1 |
| Lopes, RM | 2 |
| Rodrigues, MA | 1 |
| Eleutério, CV | 2 |
| Scoulica, E | 1 |
| Santos-Gomes, G | 1 |
| Cruz, ME | 3 |
| Pereira, J | 1 |
| Gaspar, MM | 1 |
| Gonçalves, L | 1 |
| Jiménez-Ruiz, A | 1 |
| Almeida, AJ | 1 |
| Jorge, J | 1 |
| Eleutério, C | 1 |
| Pinhal, AF | 1 |
| Sousa, AC | 1 |
| Morais, JG | 1 |
3 other studies available for trifluralin and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Hemisynthetic trifluralin analogues incorporated in liposomes for the treatment of leishmanial infections.
Topics: Animals; Antiprotozoal Agents; Cell Line; Chemistry, Pharmaceutical; Disease Models, Animal; Hemolys | 2015 |
Lipid-based nanoformulations of trifluralin analogs in the management of Leishmania infantum infections.
Topics: Animals; Antiprotozoal Agents; Diffusion; Drug Compounding; Leishmania infantum; Leishmaniasis, Visc | 2016 |
Trifluralin liposomal formulations active against Leishmania donovani infections.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Stability; Drug Storage; Female; Freeze | 2009 |